FDA News
🇺🇸 FDA Page 17FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 193–204 of 391 articles
How to Use openFDA and FAERS Data Without Misreading Safety Signals
Formycon AG Geschäftsbericht 2025: Key Insights and Implications
14 New Weight Loss Drugs: Regulatory Updates and Implications
Biotech Stocks Facing FDA Decision in June 2026: Key Insights
FDA Considers Easing Restrictions on Unproven Peptides
Commissioner's National Priority Voucher Pilot Program: Clinical Trials Insights
US FDA Proposes New Regulations on Weight-Loss Drug Compounding
Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update
2025 Drug Approvals: Biopharma's Resilience Amidst Challenges
Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide
FDA Considers Adding Peptides to Bulk Drug Compounding List
FDA Approvals in Oncology: January-March 2026